Comprehensive Analysis of Factors Improving Premenstrual Syndrome by Intake of Oligonol (low molecular weight polyphenol) - Double-blind, placebo-controlled RCT study in young women

Comprehensive Analysis of Factors Improving Premenstrual Syndrome by Intake of Oligonol (low molecular weight polyphenol) - Double-blind, placebo-controlled RCT study in young women - Comprehensive Analysis of Factors Improving Premenstrual Syndrome by Intake of Oligonol (low molecular weight polyphenol) - Double-blind, placebo-controlled RCT study in young women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000055000

Enrollment

Registered

2024-07-17

Start date

2024-06-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premenstrual syndrome(PMS)

Interventions

Subjects will be asked to take the sample once a day for 8 weeks, two capsules (100 mg per capsule) before sleep. The sample will be taken starting on the 21st day after the start of the last menstrua

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Normal menstruation

Exclusion criteria

Exclusion criteria: Menstrual irregularities, pill users, and users of antioxidant supplements different from those in this study

Design outcomes

Primary

Measure	Time frame
Subjects will be asked to take the sample once a day for 8 weeks, one capsule (200 mg per capsule) before sleep. The sample will be taken starting on the 21st day after the start of the last menstrual period (day 0) and will be taken until the 21st day after the start of menstruation 2 months later (day 56). Urine samples will be sent to Human Metabolome Technologies, Inc. for metabolomics analysis using a cohort study pack (CE-FTMS).	—

Measure

Time frame

Subjects will be asked to take the sample once a day for 8 weeks, one capsule (200 mg per capsule) before sleep. The sample will be taken starting on the 21st day after the start of the last menstrual period (day 0) and will be taken until the 21st day after the start of menstruation 2 months later (day 56). Urine samples will be sent to Human Metabolome Technologies, Inc. for metabolomics analysis using a cohort study pack (CE-FTMS).

—

Countries

Japan

Contacts

Public ContactMasaki Taga

Wayo Women's University Department of Health and Nutrition, Faculty of Home Economics

m-taga@wayo.ac.jp047-371-1591

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026